U.S., Nov. 6 -- ClinicalTrials.gov registry received information related to the study (NCT07919236) titled 'Continuous Glucose Monitoring Systems in People With Type 2 Diabetes Not Treated With Insulin' on Oct. 30.
Brief Summary: The aim of the study is to assess the influence of continuous glucose monitoring (CGM) systems on metabolic control and quality of life in people with type 2 diabetes and overweight/obesity who are not treated with insulin. Additionally, the study aims to assess the association between metabolic control of diabetes and markers of early cardiovascular disease, taking into account the impact of CGM use.
Study Start Date: Nov., 2026
Study Type: INTERVENTIONAL
Condition:
Type 2 Diabetes
Intervention:
DEVICE: Con...